HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation

BACKGROUND: Laryngeal cancer is a common malignancy of the head and neck, it’s important to find novel targets for its therapy. The 5-hydroxytryptamine receptor 7 (HTR7) belongs to the G protein-coupled receptors (GPCRs) family which are easily druggable in diseases; however, its role in laryngeal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xiaoli, Liu, Wenlin, Lu, Zhongming, Xu, Mimi, Li, Rui, Zhong, Rong, Li, Yunxian, Liu, Tao, Zhang, Siyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184477/
https://www.ncbi.nlm.nih.gov/pubmed/34164474
http://dx.doi.org/10.21037/atm-21-1069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184477/
https://www.ncbi.nlm.nih.gov/pubmed/34164474
http://dx.doi.org/10.21037/atm-21-1069

Ejemplares similares